Cancer News and Research

Latest Cancer News and Research

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Investment report on Gentium from InvestorSoup.com

Investment report on Gentium from InvestorSoup.com

AngioDynamics welcomes book on “Irreversible Electroporation”

AngioDynamics welcomes book on “Irreversible Electroporation”

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

Simcere Pharmaceutical completes Phase IV clinical study of Endostar

Simcere Pharmaceutical completes Phase IV clinical study of Endostar

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

FDA's new rule prohibits sale of cigarettes to children

FDA's new rule prohibits sale of cigarettes to children

Gene implicated in JSRDs: UCD research team publishes new information

Gene implicated in JSRDs: UCD research team publishes new information

Lab on a Chip for research on oxygen impact on brain cells

Lab on a Chip for research on oxygen impact on brain cells

Cancer radiotherapy can increase risk of cardiovascular disease later in life

Cancer radiotherapy can increase risk of cardiovascular disease later in life

Global breast cancer organization recognizes Northeast Ohio Affiliate of Susan G. Komen for the Cure

Global breast cancer organization recognizes Northeast Ohio Affiliate of Susan G. Komen for the Cure

Maple syrup has anti-oxidants, healthy biological properties: Study

Maple syrup has anti-oxidants, healthy biological properties: Study

No significant racial differences in cancer patient mortality rates: Study

No significant racial differences in cancer patient mortality rates: Study

Formatech selects Tracon Pharmaceuticals’ TRC102 inhibitor as next Fillanthropy Program candidate

Formatech selects Tracon Pharmaceuticals’ TRC102 inhibitor as next Fillanthropy Program candidate

AARDA launches campaign on family AQ

AARDA launches campaign on family AQ

Phase II Topical Interferon Alpha-2b trial for AGW: Helix BioPharma achieves last-patient-out

Phase II Topical Interferon Alpha-2b trial for AGW: Helix BioPharma achieves last-patient-out

Nanobotmodels animates future DNA repairing process

Nanobotmodels animates future DNA repairing process

Asuragen appoints BMD as exclusive distributor of Signature Oncology Products in France

Asuragen appoints BMD as exclusive distributor of Signature Oncology Products in France

SRI International researchers to disclose preliminary results of NTD detecting diagnostic at 239th ACS

SRI International researchers to disclose preliminary results of NTD detecting diagnostic at 239th ACS

Male infertility linked to increased risk of high grade prostate cancer

Male infertility linked to increased risk of high grade prostate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.